ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.
ST Pharm Dividend Announcement
• ST Pharm announced a annually dividend of ₩500.00 per ordinary share which will be made payable on 2024-04-24. Ex dividend date: 2023-12-27
• ST Pharm annual dividend for 2023 was ₩500.00
• ST Pharm's trailing twelve-month (TTM) dividend yield is 0.51%
• ST Pharm's payout ratio for the trailing twelve months (TTM) is 34.39%
ST Pharm Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-12-27 | ₩500.00 | annually | 2024-04-24 |
2022-12-28 | ₩500.00 | annually | 2022-04-22 |
2016-12-28 | ₩500.00 | annually | 2018-04-10 |
ST Pharm Dividend per year
ST Pharm Dividend Yield
ST Pharm current trailing twelve-month (TTM) dividend yield is 0.51%. Interested in purchasing ST Pharm stock? Use our calculator to estimate your expected dividend yield:
ST Pharm Financial Ratios
ST Pharm Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy ST Pharm stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.